This study will evaluate the immunogenicity of rabies vaccine at 13 months, 3 year and 5 years after initial vaccination, administered in two different post-exposure vaccination schedules
Study Type
OBSERVATIONAL
Enrollment
200
No vaccine administered; subjects only have blood sampling for
Unnamed facility
Jizhou County, Hebei, China
Rabies virus neutralizing antibody(RVNA) responses 13months, 3 years and 5 years after completion of initial vaccination series as evaluated by percentage of subjects with RVNA greater than or equal to 0.5 IU/mL
Time frame: 13 months, 3 years and 5 years after initial vaccination
Rabies virus neutralizing antibody(RVNA) responses 13months, 3 years and 5 years after completion of initial vaccination series as evaluated by geometric mean concentration
Time frame: 13months, 3 years and 5years after initial vaccination
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.